Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMinneapolis Heart Institute Foundation

About this trial

This is a multi-center, prospective, observational study designed to evaluate the impact of LV myocardial fibrosis extent assessed by CMR on LV reverse remodeling and clinical outcomes post TEER. The target sample will be up to 125 patients enrolled to achieve 100 evaluable at 6 months of follow-up. Enrollment will occur at up to eight centers.

Eligibility criteria

Qualifiers

None

Disqualifiers

Concomitant PCI and TEER

Congenital heart disease

Stage D heart failure

Uncontrolled atrial fibrillation

Trial design

Treatments tested in this trial

  • Cardiac MRI

Treatment groups

125 Participants
are divided into 1 treatment group